USAID selects Right to Care and others

USAID, Right to Care, Wits Reproductive Health Institute

JOINT MEDIA RELEASE
 
USAID selects innovative South African organisations to address HIV/AIDS globally
 
Washington / Johannesburg – Thursday, 10 December 2015: USAID has recognised the expertise of two South African-led consortia to address the global challenge of treating those infected by HIV/AIDS. These consortia are led by Right to Care and the Wits Reproductive Health and HIV Institute (Wits RHI). They will apply the innovations and lessons learned in South Africa to strengthen programmes in countries across Africa. 
 
Right to Care, a non-profit organisation that offers prevention, care, and treatment for HIV, TB, cervical cancer, medical male circumcision and sexually transmitted infections is leading the Equip consortium of five organisations that have developed a variety of innovative approaches to HIV care and treatment. These include Anova Health Institute, Khethimpilo, Maternal Adolescent and Child Health Systems (MatCH) and Partners in Hope. They have strong relationships with USAID missions and departments of health as well as more than fifty years of collective experience working in HIV/AIDS in Africa.
 
Wits RHI, a leading academic research institution working in the fields of sexual reproductive health, HIV and vaccinology, will lead efforts to simplify treatment by investigating how medicine for HIV can become more effective and affordable. The consortium includes ICAP at Columbia University, Mylan Laboratories, the University of Liverpool and the Medicines Patent Pool. The consortium will be supported by key partners including UNITAID and the South African Medical Research Council (SAMRC). 
 
The consortia will work to simplify treatment; increase HIV testing and access to treatment; link people living with HIV to care; develop laboratory capacity; target most at-risk populations to ensure they continue to follow prescribed treatment and receive the proper care, and reduce the cost and increase the effectiveness of ART through research and innovation.
 
The US Government and multinational agencies such as UNAIDS have set three key targets for the global campaign in fighting HIV/AIDS:
- 90% of HIV positive people should be identified
- 90% should be in care and on treatment
- 90% should have an undetectable viral load. 
 
On December 1, in his World AIDS Day message, President Obama reinforced the commitment of the United States to end the spread of HIV and improve the lives of all who live with it. The United States Agency for International Development (USAID) and the President’s Emergency Plan for AIDS Relief (PEPFAR) is working to fast track a path to reach the “90-90-90” targets. With the release of the new World Health Organization (WHO) guidelines recommending a “treat-all” approach, the global community must work to scale-up and expand programmes for care and treatment of HIV-positive individuals.
 
“To achieve these global HIV/AIDS targets, the global community must more than double the number of people being served. However, in a landscape of finite financial resources we must seek simple, sustainable, and inexpensive ways of delivering antiretroviral therapy (ART) programmes throughout the world,” said David Stanton, Director of the Office of HIV/AIDS at USAID.
 
Innovations in ART over the past three decades have converted HIV/AIDS from a fatal illness with few treatment options to one that is treated with a single daily tablet. However, UNAIDS estimates that global treatment targets of 30 million HIV-positive individuals on ART by 2030, which is double the present figure of 15 million individuals on ART, will create significant cost, as well as operational and manufacturing challenges for governments and health systems.
 
As ART makes up a significant cost of HIV treatment programmes, reducing costs through research and innovation will result in substantial resources being available to treat more people. 
 
Says Prof Ian Sanne, CEO of Right to Care, “We are delighted to have been selected by USAID to provide technical assistance and share the innovations which have been developed in South Africa with the rest of the world. South African organisations leading projects of this scale indicates that our experience expertise and skill have been recognised by our peers in the healthcare sector.”
 
Dr Eugene Sickle, Deputy Executive Director of Strategy and Development, Wits RHI added, “Our international consortium offers a co-ordinated attempt to establish the best and most affordable treatments for those living with HIV/AIDS. We will work with academics, researchers, business, and governments to achieve this goal.” 
 
Both consortia, supported by USAID and PEPFAR, stand poised to revolutionise treatment and care for people living with HIV/AIDS. Through collaboration and innovation to develop and sustainably provide simpler, cheaper, more effective drugs, the global community can achieve the reality of an AIDS-free generation. ENDS
 
For further information, please contact:
 
Right to Care
Michelle K Blumenau, Turquoise PR 
27 11 728 5004 / 27 83 273 9891
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
 
 
HIV testing live on air

eNCA anchors get tested live on air

 
1 December 2015 - Knowing your HIV status is vital. Getting tested for the virus requires a simple pinprick. But the pre- and post-counselling is just as important.
Sister Cynthia Yeko from the Right to Care Health Services explains how the testing process works as she tests eNCA anchors Dan Moyane and Uveka Rangappa on air.
 
 
About Right to Care

Right to Care is a non-profit organisation (Section 21) that supports and delivers prevention, care, and treatment services for HIV and associated diseases.
 

Through technical assistance, Right to Care supports the Department of Health at national level. Support at provincial level is provided primarily in five provinces: Gauteng, Mpumalanga, Northern Cape, Western Cape, and Free State. In addition, through direct service delivery, Right to Care treats patients for HIV, TB, cervical cancer, and sexually transmitted infections.
 

Support for clinical programmes is delivered through development of clinical best practices, research, training, mentoring, participation in technical committees, provision of facilities and equipment, and secondment of staff, among others services.

Funding and revenue

The chief funding and revenue streams are:

  • The President’s Emergency Plan for AIDS Relief (PEPFAR), managed by USAID
  • Global Fund
  • Private-sector donors
  • Revenue from the private sector for provision of employee wellness services (through Right to Care Health Services)

HIV care and treatment

Right to Care’s Adult HIV and Paediatric HIV programmes support the clinical care and treatment of individuals infected with HIV and associated diseases. Care and treatment is accessible through an integrated model that includes prevention, transition into care, treatment adherence, and nurse initiated and managed ARV treatment (NIMART). Loss-to-follow-up is minimised using innovative approaches, such as automated text messages and patient transfers with electronic records.
 

On-site and didactic training are provided to clinicians in the public and private sectors. In each province, centres of excellence are hubs for mentoring and training and for referrals of complicated cases.
 

In its first ten years of operation, Right to Care initiated over 230 000 patients on ARV therapy.

TB

Right to Care’s TB programme provides integrated TB/HIV services for both drug-sensitive and drug-resistant TB. Components of Right to Care’s TB strategy include use of the ‘‘3 Is’’: Intensified case finding; INH Preventative Therapy (IPT); and Infection control in health facilities.
 

TB symptom screening is done at all healthcare visits. Sputum induction facilities reduce by 10% the number of patients who cannot produce sputum, leading to improved testing rates.
 

Right to Care has spearheaded the use of the Cepheid GeneXpert MDR TB Rif for rapid diagnosis of TB and of drug resistance.
The diagnosis and management of Multidrug and Extensively Drug-Resistant TB is supported, in particular at Sizwe Tropical Diseases Hospital, Johannesburg. On an on-going basis, Right to Care collaborates in TB research studies.

Cervical cancer

At present, our most important weapon against cervical cancer is an effective screening and treatment programme to detect and remove early cervical dysplastic lesions. Right to Care trains medical officers to perform colposcopic biopsies and large loop electrical excisions (LLETZ). These cost-effective procedures have resulted in greatly improved access to treatment.
 

Mobile clinics take screening and treatment services, and other women’s health services, to remote areas.

Prevention

Right to Care’s prevention programmes include treatment as prevention, medical male circumcision (MMC), HIV counselling and testing (HCT), and prevention of mother-to-child transmission (PMTCT).
 

Right to Care advocates treatment as prevention. Among discordant couples, ARV therapy has been shown to reduce by 90% the rate of transmission from one partner to the other.
 

Annually Right to Care conducts over 300 000 HIV tests.
 

Through technical assistance and direct service delivery, Right to Care is supporting the DoH in the delivery of MMC services. MMC is offered as a comprehensive package of services that includes HCT, the provision of condoms, and education for behaviour change. MMC clinics are optimised for high-volumes.
 

Right to Care’s integrated PMTCT and Maternal & Child Health unit provides technical assistance for prevention for mothers, immunisations, reproductive health services, basic antenatal care, and PMTCT at supported sites.

Pharmacy supply chain management

Right to Care’s pharmacy programme supports the DoH at national, provincial, district, and facility levels. Programme staff members play an important role in the development of pharmaceutical policy. Right to Care supports the Medicines Control Council for the registration of medicines and for the regulation of clinical trials. Right to Care supports the site-level implementation of computerised pharmacy dispensing and information management systems. This includes integration of clinical data systems and pharmacy management systems.

Right to Care Health Services

Right to Care Health Services, a wholly owned subsidiary of Right to Care, offers organisations a comprehensive integrated wellness programme. The programme includes health and wellness screening, health risk assessments, management of chronic diseases, psychological counselling, legal and financial counselling, primary and occupational healthcare services, executive wellbeing, absenteeism, and incapacity and disability management. Clients are provided with comprehensive and integrated reports on all aspects of employee healthcare.

Training

Right to Care’s Training Department develops staff knowledge and skills in order to improve the capacity to provide quality HIV care, treatment, and support. Training courses covering a broad range of clinical subjects are offered to healthcare providers of supported sites. Didactic training is follow up with on-site mentoring.
 

Skills programmes are conducted for lay counsellors and for non-clinical staff.

Corporate governance

Right to Care is governed by a board of directors, of whom two-thirds are non-executive directors. The organisation complies with King III standards of corporate governance.
 

Right to Care consistently achieves unqualified audits from its auditing firm, Deloitte and Touche.

 

 
Our Vision & Mission

Our Vision

That every individual will have ready and affordable access to quality evidence-based medical services

Our Mission

To respond to public health needs by supporting and delivering innovative, quality healthcare solutions, based on the latest medical research and established best practices, for the prevention, treatment, and management of infectious and chronic diseases

 
Facebook

Join us on Facebook! We have two communities on Facebook.

1. For anyone interested in HIV and associated diseases: 

2. For healthcare professionals: 

 

We would love to see you there!

 
0524_1.jpg